Terms: = Leukemia AND CCNE1, CCNE, 898, ENSG00000105173, P24864
51 results:
1. Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells.
Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
[TBL] [Abstract] [Full Text] [Related]
2. CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes.
Hasan MS; Ganni E; Liu A; Guo L; Mackie AS; Kaufman JS; Marelli AJ
J Am Heart Assoc; 2024 Jan; 13(1):e026604. PubMed ID: 38156460
[TBL] [Abstract] [Full Text] [Related]
3. Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.
Daver NG; Vyas P; Kambhampati S; Al Malki MM; Larson RA; Asch AS; Mannis G; Chai-Ho W; Tanaka TN; Bradley TJ; Jeyakumar D; Wang ES; Sweet K; Kantarjian HM; Garcia-Manero G; Komrokji R; Xing G; Ramsingh G; Renard C; Zeidner JF; Sallman DA
J Clin Oncol; 2023 Nov; 41(31):4893-4904. PubMed ID: 37703506
[TBL] [Abstract] [Full Text] [Related]
4. Development and external validation of the multichannel deep learning model based on unenhanced CT for differentiating fat-poor angiomyolipoma from renal cell carcinoma: a two-center retrospective study.
Yao H; Tian L; Liu X; Li S; Chen Y; Cao J; Zhang Z; Chen Z; Feng Z; Xu Q; Zhu J; Wang Y; Guo Y; Chen W; Li C; Li P; Wang H; Luo J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15827-15838. PubMed ID: 37672075
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases.
Liu YJ; Li XH; Song YL; Zhou YC; Cai RZ; Chi PD
Cancer Med; 2023 May; 12(10):11284-11292. PubMed ID: 36965095
[TBL] [Abstract] [Full Text] [Related]
6. Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M; Flinn IW; Levy MY; Porter RF; Burke JM; Zafar SF; Misleh J; Kingsley EC; Yimer HA; Freeman B; Rao SS; Chaudhry A; Tumula PK; Gandhi MD; Manda S; Chen DY; By K; Xu L; Liu Y; Crescenzo R; Idoine A; Zhang X; Cohen A; Huang J; Sharman JP
Lancet Haematol; 2023 Jan; 10(1):e35-e45. PubMed ID: 36400069
[TBL] [Abstract] [Full Text] [Related]
7. Sex differences in childhood cancer risk among children with major birth defects: a Nordic population-based nested case-control study.
Daltveit DS; Klungsøyr K; Engeland A; Ekbom A; Gissler M; Glimelius I; Grotmol T; Madanat-Harjuoja L; Ording AG; Sørensen HT; Troisi R; Bjørge T
Int J Epidemiol; 2023 Apr; 52(2):450-465. PubMed ID: 36179253
[TBL] [Abstract] [Full Text] [Related]
8. Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid leukemia Patients Ineligible for Intensive Therapy.
Taenaka R; Obara T; Kohno K; Aoki K; Ogawa R
Intern Med; 2023 Mar; 62(5):689-695. PubMed ID: 35871587
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical and Cytogenetical Characteristics in Acute Myeloid leukemia with Myelodysplasia-Related Changes].
Ma JL; Zhou AQ; Gu SY; Chen BA; Ge Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1757-1762. PubMed ID: 34893106
[TBL] [Abstract] [Full Text] [Related]
10. Impact of pre-transplantation minimal residual disease (MRD) on the outcome of Allogeneic hematopoietic stem cell transplantation for acute leukemia.
Shen X; Pan J; Qi C; Feng Y; Wu H; Qian S; Lu H; Chen L; Li J; Miao K; Qiu H; Zhu H
Hematology; 2021 Dec; 26(1):295-300. PubMed ID: 33648437
[TBL] [Abstract] [Full Text] [Related]
11. Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
Tong J; Zhang L; Liu H; Xu X; Zheng C; Yao W; Zhu X; Tang B; Wan X; Song K; Zhang X; Sun G; Sun Z
Ann Hematol; 2021 May; 100(5):1303-1309. PubMed ID: 33469688
[TBL] [Abstract] [Full Text] [Related]
12. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
Jamalpour M; Bergquist E; Welsh M
Exp Cell Res; 2020 Dec; 397(2):112368. PubMed ID: 33220260
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
[TBL] [Abstract] [Full Text] [Related]
14. Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With Cancer.
Hussain M; Hou Y; Watson C; Moudgil R; Shah C; Abraham J; Budd GT; Tang WHW; Finet JE; James K; Estep JD; Xu B; Hu B; Cremer P; Jellis C; Grimm RA; Greenberg N; Popovic ZB; Cho L; Desai MY; Nissen SE; Kapadia SR; Svensson LG; Griffin BP; Cheng F; Collier P
Am J Cardiol; 2020 Dec; 137():118-124. PubMed ID: 32991858
[TBL] [Abstract] [Full Text] [Related]
15. The establishment and evaluation of a new model for the prediction of Children B-ALL based on TARGET: A SQUIRE-compliant study.
Gao X; Liu W
Medicine (Baltimore); 2020 May; 99(19):e20115. PubMed ID: 32384487
[TBL] [Abstract] [Full Text] [Related]
16. Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia.
He H; Kondo Y; Ishiyama K; Alatrash G; Lu S; Cox K; Qiao N; Clise-Dwyer K; St John L; Sukhumalchandra P; Ma Q; Molldrem JJ
Leukemia; 2020 Jun; 34(6):1626-1636. PubMed ID: 31908357
[TBL] [Abstract] [Full Text] [Related]
17. Boosting the apoptotic response of high-grade serous ovarian cancers with ccne1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M
Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496
[TBL] [Abstract] [Full Text] [Related]
18. MiR-15b regulates cell differentiation and survival by targeting ccne1 in APL cell lines.
Yuan Z; Zhong L; Liu D; Yao J; Liu J; Zhong P; Yao S; Zhao Y; Li L; Chen M; Liu L; Liu B
Cell Signal; 2019 Aug; 60():57-64. PubMed ID: 30965092
[TBL] [Abstract] [Full Text] [Related]
19. Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.
Vázquez-Domínguez I; González-Sánchez L; López-Nieva P; Fernández-Navarro P; Villa-Morales M; Cobos-Fernández MÁ; Sastre I; F Fraga M; F Fernández A; Malumbres M; Salazar-Roa M; Graña-Castro O; Santos J; Llamas P; López-Lorenzo JL; Fernández-Piqueras J
Oncogene; 2019 Jun; 38(23):4620-4636. PubMed ID: 30742097
[TBL] [Abstract] [Full Text] [Related]
20.
Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
[TBL] [Abstract] [Full Text] [Related]
[Next]
